期刊文献+

闽东宫颈癌普查中HPV E6/E7 mRNA及DNA的应用研究 被引量:2

原文传递
导出
摘要 目的:分析超薄液基细胞学(LCT)技术在宫颈癌筛查中的应用。方法:采集554例LCT标本,检测HPV E6/E7 mRNA,同时检测HPV E6/E7 DNA;对结果的总体分布情况及在不同细胞学级别分布情况行统计学分析。结果:以病理结果为标准,43例中不同级别的HPV E6/E7 mRNA,DNA检测情况比较,差别无统计学意义;以细胞学检测为标准,231例不同级别中HPV E6/E7 mRNA及DNA检测情况,除ASCUS外,其余级别两种检测方法差别无统计学意义;34例ASCUS标本同时行病理活检,以CIN为阳性结果,两种检测方法对阳性结果的判读,差别无统计学意义。结论:宫颈癌筛查中检测HPV E6/E7mRNA对于宫颈癌筛查具有一定的临床意义。
出处 《中国妇幼保健》 CAS 北大核心 2013年第25期4241-4243,共3页 Maternal and Child Health Care of China
  • 相关文献

参考文献7

  • 1Mtmoz N, Bosch FX, Sanjose S, et al. Epidermiologic classi- fication of human papillomavirus types associated with cervical cancer J . N Engl J Med, 2003, 348 (6) : 518.
  • 2Muioz N, Castellsagu6 X, de Gonz61ez AB, et al. Chapter 1 : HPV in the etiology of human cancer [J3 . Vaccine, 2006, 31 (3) : S3/ 1.
  • 3Robert DB, Zigui Chen, Koenraad van Doorslaer, et al. Hu- man papillomaviruses : genetic basis of carcinogenicity J3 . Public Health Genomics', 2009, 12 (5 -6) : 281.
  • 4Lie AK, Kristensen G. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical cancinoma [ J . Ex- pert Rev Mol Diagn, 2008, 8 (4) : 405.
  • 5Waldstrom M, Ornskov D. Clinical performance of a human papillomavirus messenger RNA test (Aptima HPV Assay) on residual material from archived 3 - year - old PreservCyt sam- ples with low- grade squamous intraepithelial lesion [ J3 Arch Pathol Lab Med, 2011, 135 (8) : 1052.
  • 6Benevolo M, Terrenato I, Mottolese M, et al. Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2 - positive patients [J . Cancer Causes Control, 2011, 22 (6) : 869.
  • 7Burger EA, KornCr H, Klemp M, et al. HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review [J . Gynecol Oneol, 2011, 120 (3): 430.

同被引文献39

  • 1Katzenellenbogen RA,Vliet-Gregg P,Xu M,et al. Cyto- plasmic poly (A) binding proteins regulate telomerase ac- tivity and cell growth in human papillomavinls type 16 E6-expressing keratinocytes [J]. J Virol,2010,84 (24), 12934-12944.
  • 2Van Doorslaer K,Tan Q,Xirasagar S,et al. The Papillo-mavirus Episteme:a central resource for papillomavirus sequence data and analysis. [J]. Nucleic Acids Res, 2013,41(24):571-578.
  • 3Chung HS,Hahm C,Lee M. Comparison of the clinical performances of the AdvanSure HPV scening real-time PCR,the Abbott real-time high-risk HPV test,and the Hybrid Capture high-risk HPV DNA test for cervical can- cer screening[J]. Virol Methods, 2014,205 : 57-60.
  • 4Mirzaie-Kashani E,Bouzari M,Talebi A,et al. Detection of human papillomavirus in chronic cervicitis,cervical adeno- carcinoma,intraepithelial neoplasia and squamus cell car- einoma[j]. Jundishapur J Microbiol, 2014,7(5): 9930-9935.
  • 5Martins AE,Lucena-Silva N,Garcia RG,et al. Prognostic evaluation of DNA index in H1V-HPV co-infected women cervical samples attending in reference centers for HIV- AIDS in Recife.[J]. PLoS One, 2014,9(8) : 104801.
  • 6Acera A,Manresa JM,Rodriguez D,et al. Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years:the CRICERVA study[J]. BMC Womens Health,201d, 14: 86.
  • 7Entiauspe LG,Silveira M,Nunes EM,et al. High inci- dence of oncogenic HPV genotypes found in women from Southern Brazil[J]. Braz J Microbiol, 2014,45(2) : 689-694.
  • 8Phillips CK, Hruby GW, Durak E, et al. Tissue response to surgical energy devices[J].Urology, 2008,71 (4) : 744-748.
  • 9刘立鸿,汪凯,张富春,马正海.人乳头瘤病毒(HPV)致癌机制研究进展[J].生命科学,2008,20(2):295-299. 被引量:14
  • 10郝敏,卞美璐.人乳头瘤病毒L1蛋白功能及其临床应用[J].中国实用妇科与产科杂志,2010,26(5):352-355. 被引量:17

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部